Clinical Outcomes of Impella Microaxial Devices Used to Salvage Cardiogenic Shock as a Bridge to Durable Circulatory Support or Cardiac Transplantation

被引:25
|
作者
Cheng, Richard [1 ]
Tank, Rikin [2 ]
Ramzy, Danny [3 ]
Azarbal, Babak [1 ]
Chung, Joshua [3 ]
Esmailian, Fardad [3 ]
Kobashigawa, Jon A. [1 ]
Moriguchi, Jaime D. [1 ]
Arabia, Francisco A. [3 ]
机构
[1] Cedars Sinai Heart Inst, Div Cardiol, 127 S San Vicente Blvd,Suite A3308, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA
[3] Cedars Sinai Heart Inst, Div Cardiothorac Surg, Los Angeles, CA USA
关键词
Impella; severe cardiogenic shock; percutaneous temporary circulatory support; mechanical circulatory support; bridge to decision and transplantation; EXTRACORPOREAL MEMBRANE-OXYGENATION; HEART-TRANSPLANTATION; ARTERY; METAANALYSIS; REMOVAL; ARREST;
D O I
10.1097/MAT.0000000000000877
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Temporary mechanical circulatory support (MCS) can be a bridge to decision for patients in severe cardiogenic shock who may be eligible for durable support or transplantation. Outcomes with Impella microaxial devices for salvage of severe shock in the end-stage heart failure population are not well described. Patients who underwent Impella placement as a bridge to decision, durable MCS, or transplantation were included. Eighty Impella devices (2.5 [1.3%], CP [53.8%], and 5.0 [45.0%]) were placed in 64 patients. Implant age was 56.2 +/- 12.5 years. Mean duration of assisted support was 13.2 +/- 15.1 days, and median duration per device was 7 days (interquartile range: 3-14). A total of 48.4% were in Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS 1) shock at implant, 51.6% in profile 2. Recent cardiopulmonary resuscitation (CPR) (26.7%), ventilator use (67.2%), and extracorporeal membrane oxygenation (ECMO) use (26.7%) were frequent. Forty four of sixty four (68.8%) survived to next therapy: durable MCS (40.9%), heart transplant (OHT) (36.4%), and recovery (22.7%). Overall 30 and 60 day survival were 67.2% and 65.6%, respectively. Thirty and 60 day survival conditional on having survived to next therapy were 94.1% and 91.2%, respectively. Survivors were less likely to be on ventilators (p = 0.049) or continuous renal replacement therapy (p < 0.001) but were otherwise not different from nonsurvivors by age, sex, INTERMACS profile, CPR, prevalence of ischemic cardiomyopathy, among other characteristics. Sixteen patients were directly bridged to heart transplantation, and all were alive at long-term follow-up. Impella devices can be used to salvage patients in severe heart failure as a bridge to decision, durable MCS, or transplantation. Baseline demographics are not predictive of survival. Their use for this indication is increasing and further investigations are warranted.
引用
收藏
页码:642 / 648
页数:7
相关论文
共 50 条
  • [21] IMPELLA 5.5 AS A BRIDGE TO DECISION: IMPACT OF PRIOR TEMPORARY MECHANICAL CIRCULATORY SUPPORT PRIOR TO IMPELLA 5.5 IMPLANTATION ON CLINICAL OUTCOMES
    Kieserman, Jake
    Toubat, Omar
    Kuznetsov, Ivan
    Schurr, James
    Brown, Alyson
    Cevasco, Marisa
    Bermudez, Christian
    Wald, Joyce Wanglee
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 479 - 479
  • [22] NATIONWIDE TRENDS AND OUTCOMES OF TEMPORARY MECHANICAL CIRCULATORY SUPPORT FOR CARDIOGENIC SHOCK AFTER CARDIAC SURGERY
    Vallabhajosyula, Saraschandra
    Arora, Shilpkumar
    Sakhuja, Ankit
    Lahewala, Sopan
    Kumar, Varun
    Shantha, Ghanshyam P. S.
    Gersh, Bernard J.
    Gulati, Rajiv
    Prasad, Abhiram
    Deshmukh, Abhishek J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 684 - 684
  • [23] Trends in cardiogenic shock management with percutaneous mechanical circulatory support devices in a non-transplantation centre
    Tersalvi, G. Gregorio
    Attinger-Toller, A.
    Winterton, D.
    Seiler, T.
    Cioffi, G. M.
    Madanchi, M.
    Schaffner, C.
    Koch, T.
    Moccetti, F.
    Wolfrum, M.
    Toggweiler, S.
    Bloch, A.
    Kobza, R.
    Bossard, M.
    Cuculi, F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 343 - 344
  • [24] Extracorporeal membrane oxygenation and microaxial left ventricular assist device in cardiogenic shock: Choosing the right mechanical circulatory support to improve outcomes
    Dagher, Olina
    Noly, Pierre-Emmanuel
    Ali, Walid Ben
    Bouabdallaoui, Nadia
    Geicu, Lucian
    Lamanna, Roxanne
    Malhi, Pavan
    Romero, Elizabeth
    Ducharme, Anique
    Demers, Philippe
    Lamarche, Yoan
    JTCVS OPEN, 2023, 13 : 200 - 213
  • [25] Comparison of In-Hospital Outcomes and Patterns of Mechanical Circulatory Support for Patients With Cardiogenic Shock Transferred for Impella Support vs Those With In-House Support
    Modi, Karnav
    Ghaly, Ramy
    Almohtasib, Yazan
    Patel, Adit
    Chaudhari, Jahnavi
    Bavishi, Shriya
    Khumri, Taiyeb
    Asif, Talal
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B52 - B53
  • [26] Short-Term Outcomes of Patients Presented with Cardiogenic Shock and Treated with the Impella 5.x Mechanical Circulatory Support
    Shehada, S.
    Dimitriou, A.
    Jahrkas, S.
    Balaj, I.
    Sven, A.
    Thielmann, M.
    Koch, A.
    Pizanis, N.
    Ali, H.
    Kamler, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S279 - S279
  • [27] OUTCOMES OF MECHANICAL CIRCULATORY SUPPORT FOR REFRACTORY CARDIOGENIC SHOCK IN THE ERA OF MORE ADVANCED VENTRICULAR ASSIST DEVICES
    Takayama, Hiroo
    Koeckert, Michael
    Soni, Lori
    Truby, Lauren
    Yang, Jonathan
    Horai, Tetsuya
    Ota, Takeyoshi
    Colombo, Paolo
    Uriel, Nir
    Jorde, Ulrich
    Mancini, Donna
    Naka, Yoshifumi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E875 - E875
  • [28] Acute renal failure complicating cardiogenic shock is not a contraindication to mechanical support as a bridge to cardiac transplantation
    Khot, UN
    Mishra, M
    Smedira, NG
    Young, JB
    Yeager, M
    Buda, T
    Starling, RC
    CIRCULATION, 2001, 104 (17) : 714 - 715
  • [29] Severe renal dysfunction complicating cardiogenic shock is not a contraindication to mechanical support as a bridge to cardiac transplantation
    Khot, UN
    Mishra, M
    Yamani, MH
    Smedira, NG
    Paganini, E
    Yeager, M
    Buda, T
    McCarthy, PM
    Young, JB
    Starling, RC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (03) : 381 - 385
  • [30] Clinical indications and outcomes of Impella devices for severe cardiogenic shock in COVID-19 patients: a systematic review
    Srichawla, Bahadar S.
    Kipkorir, Vincent
    Sekhon, Manraj
    ANNALS OF MEDICINE AND SURGERY, 2023, 85 (12): : 6115 - 6122